Cargando…
Heme oxygenase agonists—fluvoxamine, melatonin—are efficacious therapy for Covid-19
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Netherlands
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630687/ https://www.ncbi.nlm.nih.gov/pubmed/34846631 http://dx.doi.org/10.1007/s12192-021-01246-w |
| _version_ | 1784607410927697920 |
|---|---|
| author | Hooper, Philip L. |
| author_facet | Hooper, Philip L. |
| author_sort | Hooper, Philip L. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8630687 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Netherlands |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86306872021-11-30 Heme oxygenase agonists—fluvoxamine, melatonin—are efficacious therapy for Covid-19 Hooper, Philip L. Cell Stress Chaperones Letter to the Editor Springer Netherlands 2021-11-30 2022-01 /pmc/articles/PMC8630687/ /pubmed/34846631 http://dx.doi.org/10.1007/s12192-021-01246-w Text en © Cell Stress Society International 2021 |
| spellingShingle | Letter to the Editor Hooper, Philip L. Heme oxygenase agonists—fluvoxamine, melatonin—are efficacious therapy for Covid-19 |
| title | Heme oxygenase agonists—fluvoxamine, melatonin—are efficacious therapy for Covid-19 |
| title_full | Heme oxygenase agonists—fluvoxamine, melatonin—are efficacious therapy for Covid-19 |
| title_fullStr | Heme oxygenase agonists—fluvoxamine, melatonin—are efficacious therapy for Covid-19 |
| title_full_unstemmed | Heme oxygenase agonists—fluvoxamine, melatonin—are efficacious therapy for Covid-19 |
| title_short | Heme oxygenase agonists—fluvoxamine, melatonin—are efficacious therapy for Covid-19 |
| title_sort | heme oxygenase agonists—fluvoxamine, melatonin—are efficacious therapy for covid-19 |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630687/ https://www.ncbi.nlm.nih.gov/pubmed/34846631 http://dx.doi.org/10.1007/s12192-021-01246-w |
| work_keys_str_mv | AT hooperphilipl hemeoxygenaseagonistsfluvoxaminemelatoninareefficacioustherapyforcovid19 |